Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development?

Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development? This Medical News feature discusses the debate over human challenge trials to test the safety and efficacy of coronavirus disease 2019 (COVID-19) vaccine candidates. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Challenge Trials—Could Deliberate Coronavirus Exposure Hasten Vaccine Development?

JAMA , Volume 324 (1) – Jul 7, 2020

Loading next page...
 
/lp/american-medical-association/challenge-trials-could-deliberate-coronavirus-exposure-hasten-vaccine-F2Cef7099n

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2020.9881
Publisher site
See Article on Publisher Site

Abstract

This Medical News feature discusses the debate over human challenge trials to test the safety and efficacy of coronavirus disease 2019 (COVID-19) vaccine candidates.

Journal

JAMAAmerican Medical Association

Published: Jul 7, 2020

There are no references for this article.